Hansoh Pharmaceutical and Roche Sign ADC Strategic Collaboration and Licensing Deal Exceeding 15.5 Billion Dollars

Hansoh Pharmaceutical announced a strategic collaboration and licensing agreement with Roche with a total value exceeding 15.5 billion US dollars. The two companies will jointly accelerate the global development of novel ADC programs. The announcement did not disclose itemized figures such as upfront and milestone payments.